Table: Chugai Pharm 6-MTH group results (IFRS)

Chugai Pharmaceutical

24/07/2026 08:00

   Jul 24 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2026        Jun 30, 2025     Dec 31, 2026 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              663.33              578.46                     
                   (+14.7 pct)         (+4.6 pct)                   
  Operating          319.62              273.34                     
                   (+16.9 pct)         (+5.9 pct)                   
  Pretax
  Net                231.75              194.39                     
                   (+19.2 pct)         (+4.4 pct)                   
  EPS Basic        140.82 yen          118.13 yen                   
  EPS Diluted      140.82 yen          118.12 yen                   
  Ann Div                              272.00 yen       132.00 yen  
  -Q2 Div           66.00 yen          125.00 yen                   
  -Q4 Div                              147.00 yen        66.00 yen  
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T